No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ORGS240719C7500
- 0.75
- 0.000.00%
15min DelayClose Jul 1 10:32 ET
0.00High0.00Low
0.75Open0.75Pre Close0 Volume14 Open Interest7.50Strike Price0.00Turnover0.00%IV1173.15%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier17DDays to Expiry0.75Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.87Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Express News | Orgenesis : Received Nasdaq Hearings Panel Decision Which Granted Company Until October 14 to Regain Compliance With Bid Price and Equity Rules
Orgenesis Files to Sell 2.48M Shares of Common Stock for Holders
Orgenesis Unveils Investor Presentation With Forward-Looking Insights
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Express News | Orgenesis Q1 EPS $(0.29) Down From $0.17 YoY, Sales $141.00K Miss $12.00M Estimate
Comments
$Orgenesis(ORGS.US$ Orgenesis-Enteredinto Asset Purchase and Strategic Collaboration Agreement Which to Provide Octomera With Over $8 Mln of Initial Collaboration Payments
3
1
$Orgenesis(ORGS.US$
NEWS
Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility
Germfree and Orgenesis Inc. announce a strategic partnership to advance cell and gene therapy production. The collaboration aims to reduce production costs, increase accessibility to treatments, and revolutionize the bio-manufacturing industry. Orgenesis will co-market its Octomera platform wit...
NEWS
Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility
Germfree and Orgenesis Inc. announce a strategic partnership to advance cell and gene therapy production. The collaboration aims to reduce production costs, increase accessibility to treatments, and revolutionize the bio-manufacturing industry. Orgenesis will co-market its Octomera platform wit...
2
2
$Orgenesis(ORGS.US$ Press Release: Orgenesis Consortium Awarded EUR2.0M EUR Grant From Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing
Dow Jones· just
Dow Jones· just
$Orgenesis(ORGS.US$ the next 100x underway? I'm looking to see how cell & gene therapy decentralisation will change the pharmaceutical scenes
Read more
TrytosaveabitOP : Orgenesis Inc - Looking Forward, Our First Major Step in Transformation Was Recent Transaction to Regain 100% Ownership of Octomera